Alenka Mavri
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 15
-
- Atrial Fibrillation Management and Outcomes 18
- Cardiac Arrhythmias and Treatments 11
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Cardiac electrophysiology and arrhythmias 4
- Hematology top 5%
- Epidemiology top 5%
- Adipokines, Inflammation, and Metabolic Diseases 10
-
- Blood properties and coagulation 6
-
- Protease and Inhibitor Mechanisms 6
Alenka Mavri
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 91
- Internal Medicine 224
- Cardiology and Cardiovascular Medicine 483
- Hematology 194
- Endocrinology, Diabetes and Metabolism 248
- Epidemiology 494
Countries citing papers authored by Alenka Mavri
This map shows the geographic impact of Alenka Mavri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alenka Mavri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alenka Mavri more than expected).
Fields of papers citing papers by Alenka Mavri
This network shows the impact of papers produced by Alenka Mavri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alenka Mavri. The network helps show where Alenka Mavri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alenka Mavri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 21 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 8 | |
| 8 | 2019 | 34 | |
| 9 | Slovenian recommendations for the detection and treatment of venous thrombosis | 2016 | 1 |
| 10 | 2016 | 29 | |
| 11 | Dabigatran and rivaroxaban in the patients with atrial fibrillation and venous thrombembolism: our first clinical experience | 2015 | 0 |
| 12 | 2014 | 15 | |
| 13 | 2005 | 10 | |
| 14 | 2004 | 42 | |
| 15 | 2003 | 277 | |
| 16 | 2003 | 86 | |
| 17 | 2001 | 29 | |
| 18 | 2001 | 41 | |
| 19 | 2001 | 68 | |
| 20 | 2001 | 91 |
About Alenka Mavri
Alenka Mavri is a scholar working on Internal Medicine, Toxicology and Cardiology and Cardiovascular Medicine, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (18 papers), Venous Thromboembolism Diagnosis and Management (15 papers), Cardiac Arrhythmias and Treatments (11 papers), Adipokines, Inflammation, and Metabolic Diseases (10 papers), Blood properties and coagulation (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Cardiac electrophysiology and arrhythmias (4 papers). The work is most often cited by research in Internal Medicine (224 citations), Cardiology and Cardiovascular Medicine (483 citations) and Hematology (194 citations). Alenka Mavri has collaborated with scholars based in Slovenia, Sweden and France. Frequent co-authors include Marie‐Christine Alessi, Pierre‐Emmanuel Morange, Mojca Stegnar, I. Juhan-Vague, I. Juhan‐Vague, Nina Vene, Delphine Bastelica, B Berthet, Katarina Košmelj and Mojca Stegnar.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.